To best understand parasite, host, and vector morphologies, host–parasite interactions, and
to develop new drug and vaccine targets, structural data should, ideally, be obtained and …

Protein and phosphoinositide kinases have been successfully exploited as drug targets in
various disease areas, principally in oncology. In malaria, several protein kinases are under …

Glucose metabolism is known to orchestrate oncogenesis. Whether glucose serves as a
signaling molecule directly regulating oncoprotein activity for tumorigenesis remains elusive …

The apicomplexan parasite Toxoplasma gondii is the causative agent of toxoplasmosis, a
global disease that significantly impacts human health. The clinical manifestations are …

Chagas disease is one of the world's neglected tropical diseases, caused by the human
pathogenic protozoan parasite Trypanosoma cruzi. There is currently a lack of effective and …

The protozoan parasite Plasmodium falciparum is the causative pathogen of the most
severe form of malaria, for which novel strategies for treatment are urgently required. The …

The protozoan parasite Plasmodium falciparum causes the most severe form of malaria and
is highly dependent on glycolysis. Glycolytic enzymes were shown to be massively redox …

The protozoan parasite Plasmodium falciparum (P. falciparum) is the causative pathogen of
the most severe form of malaria. For its survival and replication in human erythrocytes, P …

Malaria, a deadly tropical disease transmitted by infected mosquitos, is caused by
Plasmodium parasites. Plasmodium falciparum is the most pathogenic form, responsible …